Margarete Rudloff is a seasoned professional in clinical data management and monitoring, currently serving as the Director of Central Monitoring at Fortrea since June 2023. Prior experience includes key leadership roles at Labcorp Drug Development from January 2013 to June 2023, overseeing Clinical Development in Germany, Austria, and Switzerland, along with positions in monitoring operations and risk-based monitoring. Margarete's career also encompasses significant contributions at Covance, INC Research, Kendle, and gmi, demonstrating extensive expertise in project management, client relationships, and data operations across Europe and Asia Pacific. Margarete holds a degree as a Medical Documentalist from Justus-Liebig-University in Gießen, Germany, focusing on data operations, medicine, mathematics, statistics, and public health law.